BioStem Technologies, Inc. (BSEM) vs Envoy Medical, Inc. (COCH)
A side-by-side comparison of BioStem Technologies, Inc. and Envoy Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BSEM
BioStem Technologies, Inc.
$2.54HealthcareDelayed quote: Oct 6, 2026, 1:04 PM EDT
COCH
Envoy Medical, Inc.
$0.67HealthcareDelayed quote: Oct 6, 2026, 12:44 PM EDT
Total return — BSEM vs COCH
growth of $100 · dividends reinvested · last 5yBSEM +98.6% (+14.7%/yr)COCH -93.3% (-41.8%/yr)BSEM compounded faster over this window
Log scale — wide-divergence pair
BSEM COCH
BSEM vs COCH: by the numbers
- •COCH is the larger company ($51M vs $43M market cap).
- •Both run net losses; BSEM's is the smaller (-13.86% vs -11304.83% net margin).
Metrics side by side
Valuation
| Metric | BSEM | COCH |
|---|---|---|
| P/S ratio | N/A | 247.99 |
| P/B ratio | 1.56 | 15.54 |
Profitability
| Metric | BSEM | COCH |
|---|---|---|
| Gross margin | 93.13% | -262.66% |
| Operating margin | -1.45% | -9240.66% |
| Net margin | -13.86% | -11304.83% |
| ROE | -102.45% | -708.48% |
| ROIC | -80.92% | -208.76% |
Growth (annualized)
| Metric | BSEM | COCH |
|---|---|---|
| Total return CAGR (5Y) | 15.72% | -41.73% |
Frequently asked
- How have BSEM and COCH total returns compared?
- Over the past 5 years, BSEM delivered 15.72% and COCH delivered -41.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.